Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity
about
Dual localization of glutathione S-transferase in the cytosol and mitochondria: implications in oxidative stress, toxicity and diseaseRole of endoplasmic reticulum stress in drug-induced toxicityXenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the LiverMetabolic methanol: molecular pathways and physiological rolesFunctional roles of protein nitration in acute and chronic liver diseasesLiver transcriptomic networks reveal main biological processes associated with feed efficiency in beef cattle.Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunctionA cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophenRole of Mitochondria in Alcoholic Liver DiseaseThe role of CYP2E1 in alcohol metabolism and sensitivity in the central nervous system.Optimization and validation of a label-free MRM method for the quantification of cytochrome P450 isoforms in biological samples.Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals.A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells.Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases.Eicosanoids in metabolic syndrome.Alcohol induces mitochondrial redox imbalance in alveolar macrophages.The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain.Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells.The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs.Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.Hormonal regulation of hepatic drug biotransformation and transport systems.Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells.Protective effect of Mutellina purpurea polyphenolic compounds in doxorubicin-induced toxicity in H9c2 cardiomyocytes.PharmGKB summary: isoniazid pathway, pharmacokinetics.Inhibition of CYP2E1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction and apoptosis.Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin.Evolutionary origin of mitochondrial cytochrome P450.Cytochrome P450 expression in mouse brain: specific isoenzymes involved in Phase I metabolizing system of porphyrinogenic agents in both microsomes and mitochondria.Detection of Dual Targeting and Dual Function of Mitochondrial Proteins in Yeast.
P2860
Q24633323-FE6DFF84-AE2E-47B8-AC4B-3D2832821036Q26765518-5F7C323A-5A70-4399-A326-0860ADB92599Q26800213-61498131-1B0D-46CC-BAE0-78D2D658EA59Q27000276-2A36F8CA-7E9A-4628-A4C9-DE9E9F468FBEQ27008888-15DB012B-AA6D-42EE-8129-BE51CF17246CQ27316949-B110677E-0EA9-486C-8F71-976E40ADC55CQ28082228-66ADE264-88D1-4DE4-9BFB-8DC0BA60F025Q28396747-1171C35F-AE68-4A44-B337-E768D90EB9FCQ34377243-8F6F49D6-78CA-43D3-B4D3-6DA52239D2CAQ35039548-71593F70-E0DC-47B8-922B-8DF5EF191F2EQ35192807-ED6029CE-48E6-4DD3-A2F7-5D33293FCBDBQ35482371-A1C7549C-0B50-426C-A157-454A84FE0C99Q35768905-CF1F184C-1857-4B9C-9CB0-0ABC14E11832Q36590615-29A7E1B0-F74B-4623-A977-FBFEAF4B0A6FQ36911098-C1BF9FD0-25B5-4F69-B219-98CEA0CD30C6Q37408747-3E36A9A0-4995-4F8A-BD8D-54C825C1EA29Q37601909-3D9A3F5F-E423-44B0-B1D5-3208C8C15760Q37691228-3CB9A21C-4106-4FE2-ABF5-44EF05A4EC29Q38010769-1DA90DAA-5D52-4BBE-BA7C-367DC261E46EQ38099753-96FD8F8F-41EB-4F51-A44A-445950A7C6D7Q38165145-B6E4A23D-7D56-4FA3-B323-D4CD224A9336Q38208324-0257778B-2401-4CB3-9B14-A46B278E3A81Q38687132-56809AB3-6372-449E-BD1B-5D4E8029842EQ38868301-D1A1FF1B-A87F-4735-B0D3-4601EC561BF2Q39242669-4C22939B-B8AD-4F80-87DE-9553315D5C96Q42090708-4710689F-F722-410E-8B77-5058B2402E33Q42404252-B656DF45-5B64-4D80-932D-E7D6DD0952E7Q46028092-5E340D54-5E97-4533-891E-BFF063D129A9Q46397638-5AD031E3-2D66-419C-80DE-226D04EE066EQ47791484-FC7BCE6A-0325-45FD-9D66-240ADF5009FEQ51105000-78CED737-20EC-4DD9-A1D1-5A746588FF55
P2860
Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@ast
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@en
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@nl
type
label
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@ast
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@en
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@nl
prefLabel
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@ast
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@en
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@nl
P2093
P2860
P921
P1433
P1476
Mechanisms of mitochondrial ta ...... le in liver injury and obesity
@en
P2093
Bernard Fromenty
Laetitia Knockaert
Marie-Anne Robin
P2860
P304
P356
10.1111/J.1742-4658.2011.08357.X
P407
P577
2011-11-01T00:00:00Z